• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兰伯特-伊顿肌无力综合征的临床表现、电生理特征及长期随访:6例患者系列报道

Clinical presentations, electrophysiologic features, and long-term follow-up in Lambert-Eaton myasthenic syndrome: a series of six patients.

作者信息

Alhammad Reem M, Alshamlan Yafa, Alneseyan Ruwa, Al-Harbi Talal M, Alhijab Ali, Alanazy Mohammed H

机构信息

Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Department of Neurology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.

出版信息

Front Neurol. 2024 Dec 13;15:1525155. doi: 10.3389/fneur.2024.1525155. eCollection 2024.

DOI:10.3389/fneur.2024.1525155
PMID:39734633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11671300/
Abstract

BACKGROUND

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of the presynaptic neuromuscular junction associated with antibody mediated dysfunction of voltage-gated calcium channels (VGCCs). LEMS can exist as a paraneoplastic syndrome, paraneoplastic-LEMS (P-LEMS), when associated with tumors, most commonly, small cell lung carcinoma (SCLC) or as a non-paraneoplastic condition (NP-LEMS) when no malignancies are detected.

METHODS

A retrospective chart review was conducted in 3 tertiary hospitals in Saudi Arabia for patients diagnosed with LEMS between January 2010 and January 2020. Patients meeting all the following criteria were included: (1) weakness or fatigability of one or more extremity or oculo-bulbar muscles, (2) 60% or higher increment of compound muscle action potential (CMAP) amplitudes immediately following isometric exercise, and (3) positive serum P/Q type VGCC antibodies. Clinical, laboratory, and electrophysiologic features, as well as radiologic imaging modalities performed for tumor screening were reviewed.

RESULTS

The study included six patients diagnosed with LEMS, split evenly between P-LEMS and NP-LEMS. Fatigability, particularly in the lower extremities, and dyspnea on exertion were commonly reported symptoms. Low CMAP amplitudes were more frequently seen in NP-LEMS as compared to P-LEMS when recorded from both abductor pollicis brevis and abductor digiti minimi muscles. An incremental response above 60% in post activation CMAPs was detected at similar rates following variable durations of isometric exercise (10, 15, and 20 s). Tumor types detected in 3 patients with P-LEMS are SCLC, breast carcinoma, colon adenocarcinoma, and prostate acinar adenocarcinoma. Triple malignancy was detected in one patient.

CONCLUSION

This is the first study to describe clinical and electrophysiologic features of LEMS in an Arab ethnic cohort. Early recognition of LEMS has a significant impact on prognosis, especially given the aggressive nature of associated cancers such as SCLC.

摘要

背景

兰伯特 - 伊顿肌无力综合征(LEMS)是一种突触前神经肌肉接头的自身免疫性疾病,与电压门控钙通道(VGCCs)抗体介导的功能障碍相关。当与肿瘤相关时,LEMS可表现为副肿瘤综合征,即副肿瘤性LEMS(P - LEMS),最常见的是与小细胞肺癌(SCLC)相关;当未检测到恶性肿瘤时,则表现为非副肿瘤性疾病(NP - LEMS)。

方法

对沙特阿拉伯3家三级医院2010年1月至2020年1月期间诊断为LEMS的患者进行回顾性病历审查。纳入符合以下所有标准的患者:(1)一个或多个肢体或眼外肌肌无力或易疲劳;(2)等长运动后复合肌肉动作电位(CMAP)幅度立即增加60%或更高;(3)血清P/Q型VGCC抗体阳性。对临床、实验室和电生理特征以及用于肿瘤筛查的影像学检查方式进行了回顾。

结果

该研究纳入了6例诊断为LEMS的患者,P - LEMS和NP - LEMS各占一半。易疲劳,尤其是下肢易疲劳,以及运动时呼吸困难是常见症状。从拇短展肌和小指展肌记录时,与P - LEMS相比,NP - LEMS中CMAP幅度较低更为常见。在不同时长(10、15和20秒)的等长运动后,激活后CMAP增加超过60%的反应发生率相似。3例P - LEMS患者检测到的肿瘤类型为SCLC、乳腺癌、结肠腺癌和前列腺腺泡腺癌。1例患者检测到三重恶性肿瘤。

结论

这是第一项描述阿拉伯族裔队列中LEMS临床和电生理特征的研究。早期识别LEMS对预后有重大影响,特别是考虑到相关癌症如SCLC的侵袭性。

相似文献

1
Clinical presentations, electrophysiologic features, and long-term follow-up in Lambert-Eaton myasthenic syndrome: a series of six patients.兰伯特-伊顿肌无力综合征的临床表现、电生理特征及长期随访:6例患者系列报道
Front Neurol. 2024 Dec 13;15:1525155. doi: 10.3389/fneur.2024.1525155. eCollection 2024.
2
[P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].[兰伯特-伊顿肌无力综合征中的P/Q型钙通道抗体]
Brain Nerve. 2018 Apr;70(4):341-355. doi: 10.11477/mf.1416201007.
3
Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer. Lambert-Eaton 肌无力综合征(LEMS):一种罕见的自身免疫性突触前疾病,常与癌症相关。
J Neurol. 2017 Sep;264(9):1854-1863. doi: 10.1007/s00415-017-8541-9. Epub 2017 Jun 12.
4
[Lambert-Eaton myasthenic syndrome].[兰伯特-伊顿肌无力综合征]
Brain Nerve. 2011 Jul;63(7):745-54.
5
[Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].[兰伯特-伊顿肌无力综合征中针对突触前P/Q型电压门控钙通道的自身抗体]
Brain Nerve. 2013 Apr;65(4):441-8.
6
Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.兰伯特-伊顿肌无力综合征:基于突触前钙稳态寻找替代自身免疫靶点及可能的代偿机制。
J Neuroimmunol. 2008 Sep 15;201-202:145-52. doi: 10.1016/j.jneuroim.2008.04.040. Epub 2008 Jul 24.
7
Voltage gated calcium channel antibody-related neurological diseases.电压门控钙通道抗体相关神经系统疾病
World J Clin Cases. 2015 Mar 16;3(3):293-300. doi: 10.12998/wjcc.v3.i3.293.
8
Lambert-Eaton Myasthenic syndrome: early diagnosis is key.兰伯特-伊顿肌无力综合征:早期诊断是关键。
Degener Neurol Neuromuscul Dis. 2019 May 13;9:27-37. doi: 10.2147/DNND.S192588. eCollection 2019.
9
Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.兰伯特-伊顿肌无力综合征——诊断、发病机制与治疗
Clin Neurophysiol. 2014 Dec;125(12):2328-36. doi: 10.1016/j.clinph.2014.06.031. Epub 2014 Jul 4.
10
Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.口咽神经内分泌癌相关的副肿瘤性小脑变性和兰伯特-伊顿肌无力综合征
Intern Med. 2018 Feb 15;57(4):587-590. doi: 10.2169/internalmedicine.9333-17. Epub 2017 Nov 1.

本文引用的文献

1
Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis.血清阳性/血清阴性重症肌无力患者的电生理研究
Curr J Neurol. 2021 Jul 6;20(3):120-124. doi: 10.18502/cjn.v20i3.7686.
2
Lambert-Eaton Myasthenic Syndrome and Botulism. Lambert-Eaton 肌无力综合征与肉毒中毒。
Continuum (Minneap Minn). 2022 Dec 1;28(6):1596-1614. doi: 10.1212/CON.0000000000001205.
3
Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan.日本兰伯特-伊顿肌无力综合征的全国性调查。
BMJ Neurol Open. 2022 Sep 5;4(2):e000291. doi: 10.1136/bmjno-2022-000291. eCollection 2022.
4
Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.阿替利珠单抗致小细胞肺癌患者 Lambert-Eaton 肌无力综合征
Intern Med. 2022 Jun 1;61(11):1739-1742. doi: 10.2169/internalmedicine.8387-21. Epub 2021 Oct 26.
5
An Extensive-stage Small-cell Lung Cancer Case With Preexisting Lambert-Eaton Myasthenic Syndrome Successfully Treated With an Immune Checkpoint Inhibitor.一例合并兰伯特-伊顿肌无力综合征的广泛期小细胞肺癌患者成功接受免疫检查点抑制剂治疗
Clin Lung Cancer. 2022 May;23(3):e273-e275. doi: 10.1016/j.cllc.2021.09.001. Epub 2021 Sep 17.
6
3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trials.3,4-二氨基吡啶治疗成人兰伯特-伊顿肌无力综合征:随机对照试验的荟萃分析
BMC Neurol. 2021 Sep 25;21(1):371. doi: 10.1186/s12883-021-02405-3.
7
Direct comparison of median and ulnar repetitive nerve stimulation in generalized myasthenia gravis.对比研究正中神经和尺神经重复神经刺激在全身性重症肌无力中的应用。
Muscle Nerve. 2021 Oct;64(4):490-493. doi: 10.1002/mus.27366. Epub 2021 Jul 14.
8
Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma.在默克尔细胞癌的检查点抑制下,使用免疫球蛋白减轻副肿瘤性兰伯特-伊顿肌无力综合征。
Neurol Res Pract. 2020 Dec 9;2:52. doi: 10.1186/s42466-020-00099-5. eCollection 2020.
9
Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.Lambert-Eaton 肌无力综合征患者的长期随访、生活质量和生存情况。
Neurology. 2020 Feb 4;94(5):e511-e520. doi: 10.1212/WNL.0000000000008747. Epub 2019 Dec 12.
10
Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer.一名小细胞肺癌患者中,继发于纳武单抗和伊匹单抗的兰伯特-伊顿肌无力综合征
Case Rep Neurol Med. 2019 Jul 2;2019:5353202. doi: 10.1155/2019/5353202. eCollection 2019.